Clinical Trial Update: Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone [Phase 3]

View source ↗

Summary

A Phase 3 trial investigated retinal effects of combining photodynamic therapy with intravitreal Triamcinolone for neovascular age-related macular degeneration.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Kenalog (Triamcinolone acetonide) (Triamcinolone acetonide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Neovascular Age Related Macular Degeneration | Phase 3 | Status: COMPLETED